Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC
Clinical trial NCT05386524 · UNKNOWN
Trial details
- NCT number
- NCT05386524
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2025-03-15
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.